Accordingly, we aimed to evaluate the presence of CD45RO + and LAG3 + TILs in the CT and IM and their impacts on outcomes in CRC with particular focus on tumor location (right and left colon tumors). The gene discussed is LAG3; the disease is colorectal carcinoma.